The Journal of Psychology
April 1, 1955
Murray E. Jarvik, Harold A. Abramson, Martin Hirsch et al.
14 citations
(1955). Lysergic Acid Diethylamide (LSD-25): VIII. Effect on Arithmetic Test Performance. The Journal of Psychology: Vol. 39, No. 2, pp. 465-473.
The Journal of Psychology
April 1, 1955
Murray E. Jarvik, Harold A. Abramson, Martin Hirsch
50 citations
(1955). Lysergic Acid Diethylamide (LSD-25): VI. Effect upon Recall and Recognition of Various Stimuli. The Journal of Psychology: Vol. 39, No. 2, pp. 443-454.
Journal of Mental Science
1955
N. Agnew, A. Hoffer
26 citations
Theoretical models ranging from neurological to analytical have been introduced in the hope of providing new insights into psychopathology. The flesh and blood model is of more recent origin in this field. The experimental or model psychosis results from giving “normals” drugs which bring about a psychotic-like experience for a few hours. As is the case with theoretical models, the flesh and...
The Journal of Psychology
1955
Harold A. Abramson, Murray E. Jarvik, Matthew R. Kaufman et al.
126 citations
(1955). Lysergic Acid Diethylamide (LSD-25): I. Physiological and Perceptual Responses. The Journal of Psychology: Vol. 39, No. 1, pp. 3-60.
Science
December 31, 1954
Akira Horita, James M. Dille
44 citations
Article MetricsDownloadsCitationsNo data available.01JulAugSepOctNovDec90Total6 Months12 MonthsTotal number of downloads for the most recent 6 whole calendar months.
Journal of Mental Science
April 1, 1954
R. A. Sandison, A. M. Spencer, J. D. A. Whitelaw
191 citations
D-lysergic acid diethylamide (LSD 25) was first prepared in 1938 by Stoll and Hofmann. It is the synthetic amide of d-lysergic acid with a secondary amine, diethylamine and belongs to the ergonovine group of ergot alkaloids all of which have lysergic acid as a base. After its ingestion in minute doses, it induces psychic states in which the subject becomes aware of repressed memories and other...
Journal of Mental Science
April 1, 1954
R. A. Sandison
90 citations
Recent work by the author and his colleagues (Sandison, Spencer and Whitelaw, 1954) has established that lysergic acid diethylamide is of great value in the psychotherapy of the neuroses. This paper attempts to examine in rather more detail the possible mechanism of action of the drug in terms of dynamic psychology. It is now generally accepted that the psychoneuroses are the result of a faulty...
The Journal of Nervous and Mental Disease
February 1, 1954
Harry H. Pennes
48 citations
* From the Department of Experimental Psychiatry (Paul H. Hoch, M.D.), New York State Psychiatric Institute.
American Journal of Psychiatry
June 1, 1952
Charles Savage
137 citations
Lysergic acid diethylamide (LSD-25 Sandoz) given orally in single doses as low as 20 micrograms produces depersonalization, derealization, and increased imagery in "normal" individuals. Larger doses are required to produce the same effect in psychotic patients. Of 15 patients with depressive reactions, 3 recovered and 4 improved after one month's treatment with daily oral doses of 20-100...
American Journal of Psychiatry
February 1, 1952
Paul H. Hoch, James P. Cattell, Harry H. Pennes
116 citations
The effects of mescaline and lysergic acid were studied in schizophrenic patients. It was found that physiological changes were produced in these patients and that their mental symptomatology was markedly aggravated. The observations made with the above-mentioned drugs on normal individuals were compared with those seen in schizophrenic patients. Mescaline and lysergic acid are drugs that...